Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity

Journal of Histochemistry and Cytochemistry

Volumn 62, Issue 6, 2014, Pages 395-404

  Marchalant, Yannick ^a   Brownjohn, Philip W ^b   Bonnet, Amandine ^a   Kleffmann, Torsten ^b   Ashton, John C ^b  

^a Mediterranée University   (France)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

cannabinoid; CB2; immunoblot; mass spectrometry; membrane enrichment; western blot

Indexed keywords

CANNABINOID 2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY AND IMMUNOGLOBULIN STRUCTURE, FUNCTION AND PRODUCTION; ANTIBODY SENSITIVITY; ANTIBODY SPECIFICITY; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 84901443454     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155414530995     Document Type: Article

References (36)

1. Aebersold R,Burlingame AL,Bradshaw RA.Western Blots versus Selected Reaction Monitoring Assays: Time to Turn the Tables?.Mol Cell Proteomics. 2013;12:2381-2382.
2. Alvaro-Bartolome M,Garcia-Sevilla JA.Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.Neuroscience. 2013;247:294-308.
3. Ashton JC.The use of knockout mice to test the specificity of antibodies for cannabinoid receptors.Hippocampus. 2011;22:643-644.
4. Atwood BK,Mackie K.CB2: a cannabinoid receptor with an identity crisis.Br J Pharmacol. 2010;160:467-479.
5. Baek JH,Darlington CL,Smith PF,Ashton JC.Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB(2) receptor.J Neurosci Methods. 2013;216:87-95.
6. Beltramo M,Bernardini N,Bertorelli R,Campanella M,Nicolussi E,Fredduzzi S,Reggiani A.CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.Eur J Neurosci. 2006;23:1530-1538.
7. Benito C,Nunez E,Tolon RM,Carrier EJ,Rabano A,Hillard CJ,Romero J.Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.J Neurosci. 2003;23:11136-11141.
8. Bogen B,Gleditsch L,Teig A.T-cell receptor alpha haplotype influences V alpha epitope expression on both cortisone-resistant thymocytes and lymph node T cells.Scand J Immunol. 1993;37:690-695.
9. Brownjohn PW,Ashton JC.Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.Neuroscience. 2012;203:180-193.
10. Buckley NE,McCoy KL,Mezey E,Bonner T,Zimmer A,Felder CC,Glass M,Zimmer A.Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.Eur J Pharmacol. 2000;396:141-149.
11. Cecyre B,Thomas S,Ptito M,Casanova C,Bouchard JF.Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.Naunyn-Schmiedebergs Arch Pharmacol. 2013;387:175-184.
12. Choi IY,Ju C,Anthony Jalin AM,Lee da I,Prather PL,Kim WK.Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.Am J Pathol. 2013;182:928-939.
13. Curto-Reyes V,Boto T,Hidalgo A,Menendez L,Baamonde A.Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.Eur J Pharmacol. 2011;668:184-189.
14. Curto-Reyes V,Llames S,Hidalgo A,Menendez L,Baamonde A.Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.Br J Pharmacol. 2010;160:561-573.
15. den Boon FS,Chameau P,Schaafsma-Zhao Q,van Aken W,Bari M,Oddi S,Kruse CG,Maccarrone M,Wadman WJ,Werkman TR.Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors.Proc Natl Acad Sci U S A. 2012;109:3534-3539.
16. Filppula S,Yaddanapudi S,Mercier R,Xu W,Pavlopoulos S,Makriyannis A.Purification and mass spectroscopic analysis of human CB2 cannabinoid receptor expressed in the baculovirus system.J Pept Res. 2004;64:225-236.
17. Galiegue S,Mary S,Marchand J,Dussossoy D,Carriere D,Carayon P,Bouaboula M,Shire D,Le Fur G,Casellas P.Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.Eur J Biochem. 1995;232:54-61.
18. Gong JP,Onaivi ES,Ishiguro H,Liu QR,Tagliaferro PA,Brusco A,Uhl GR.Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006;1071:10-23.
19. Griffin G,Tao Q,Abood ME.Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.J Pharmacol Exp Ther. 2000;292:886-894.
20. Grimsey NL,Goodfellow CE,Scotter EL,Dowie MJ,Glass M,Graham ES.Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!.J Neurosci Methods. 2008;171:78-86.
21. Hohmann AG,Herkenham M.Cannabinoid receptors undergo axonal flow in sensory nerves.Neuroscience. 1999;92:1171-1175.
22. Hsieh GC,Pai M,Chandran P,Hooker BA,Zhu CZ,Salyers AK,Wensink EJ,Zhan C,Carroll WA,Dart MJ,Yao BB,Honore P,Meyer MD.Central and peripheral sites of action for CB receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.Br J Pharmacol. 2011;162:428-440.
23. Ikeda H,Ikegami M,Kai M,Ohsawa M,Kamei J.Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice.Neuroscience. 2013;250:446-454.
24. Kall L,Canterbury JD,Weston J,Noble WS,MacCoss MJ.Semi-supervised learning for peptide identification from shotgun proteomics datasets.Nat Methods. 2007;4:923-925.
25. Marini P,Cascio MG,King A,Pertwee RG,Ross RA.Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors.Br J Pharmacol. 2013;169:887-899.
26. Matias I,Pochard P,Orlando P,Salzet M,Pestel J,Di Marzo V.Presence and regulation of the endocannabinoid system in human dendritic cells.Eur J Biochem. 2002;269:3771-3778.
27. Munro S,Thomas KL,Abu-Shaar M.Molecular characterization of a peripheral receptor for cannabinoids.Nature. 1993;365:61-65.
28. Schatz AR,Lee M,Condie RB,Pulaski JT,Kaminski NE.Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.Toxicol Appl Pharmacol. 1997;142:278-287.
29. Shevchenko A,Jensen ON,Podtelejnikov AV,Sagliocco F,Wilm M,Vorm O,Mortensen P,Boucherie H,Mann M.Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels.Proc Natl Acad Sci U S A. 1996;93:14440-14445.
30. Silva JC,Gorenstein MV,Li GZ,Vissers JP,Geromanos SJ.Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.Mol Cell Proteomics. 2006;5:144-156.
31. Walczak JS,Pichette V,Leblond F,Desbiens K,Beaulieu P.Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes.J Neurosci Res. 2006;83:1310-1322.
32. Walczak JS,Pichette V,Leblond F,Desbiens K,Beaulieu P.Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain.Neuroscience. 2005;132:1093-1102.
33. Watanabe S,Quan CP,Smith LR,Kuroi K,Bouvet JP.Homology of partial primary sequences between alpha-enolase and a suppressive lymphokine from human T cells.Immunol Inv. 1996;25:397-404.
34. Wotherspoon G,Fox A,McIntyre P,Colley S,Bevan S,Winter J.Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.Neuroscience. 2005;135:235-245.
35. Zhang J,Hoffert C,Vu HK,Groblewski T,Ahmad S,O'Donnell D.Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.Eur J Neurosci. 2003;17:2750-2754.
36. Zvonok N,Yaddanapudi S,Williams J,Dai S,Dong K,Rejtar T,Karger BL,Makriyannis A.Comprehensive proteomic mass spectrometric characterization of human cannabinoid CB2 receptor.J Proteome Res. 2007;6:2068-2079.